Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1. (Q40285314)

19 September 2017

Requirements for capsid-binding and an effector function in TRIMCyp-mediated restriction of HIV-1. (English)

1 reference

19 September 2017

9

Joseph Sodroski

1 reference

19 September 2017

5

Matthew Stremlau

1 reference

19 September 2017

1

Felipe Diaz-Griffero

1 reference

19 September 2017

Nick Vandegraaff

2

1 reference

19 September 2017

Yuan Li

3

1 reference

19 September 2017

Kathleen McGee-Estrada

4

1 reference

19 September 2017

Sohanya Welikala

6

1 reference

19 September 2017

Zhihai Si

7

1 reference

19 September 2017

Alan Engelman

8

1 reference

19 September 2017

language of work or name

English

0 references

publication date

2 May 2006

1 reference

19 September 2017

1 reference

19 September 2017

351

1 reference

19 September 2017

404-419

1 reference

19 September 2017

2

1 reference

Restriction of lentivirus in monkeys

19 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Catalysis and binding of cyclophilin A with different HIV-1 capsid constructs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Catalysis of cis/trans isomerization in native HIV-1 capsid by human cyclophilin A

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

A quantitative assay for HIV DNA integration in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Naturally occurring capsid substitutions render HIV-1 cyclophilin A independent in human cells and TRIM-cyclophilin-resistant in Owl monkey cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Endocytosis is a critical step in entry of subgroup B avian leukosis viruses.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Capsid processing requirements for abrogation of Fv1 and Ref1 restriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Structural requirements for recognition of the human immunodeficiency virus type 1 core during host restriction in owl monkey cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Crystal structure of human cyclophilin A bound to the amino-terminal domain of HIV-1 capsid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Assembly properties of the human immunodeficiency virus type 1 CA protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Assembly and analysis of conical models for the HIV-1 core.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Altered HIV-1 Gag protein interactions with cyclophilin A (CypA) on the acquisition of H219Q and H219P substitutions in the CypA binding loop

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Restriction of multiple divergent retroviruses by Lv1 and Ref1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Retrovirus resistance factors Ref1 and Lv1 are species-specific variants of TRIM5alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Species-specific tropism determinants in the human immunodeficiency virus type 1 capsid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Cyclophilin interactions with incoming human immunodeficiency virus type 1 capsids with opposing effects on infectivity in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

The contribution of RING and B-box 2 domains to retroviral restriction mediated by monkey TRIM5alpha.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Model for lentivirus capsid core assembly based on crystal dimers of EIAV p26

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Replication of phenotypically mixed human immunodeficiency virus type 1 virions containing catalytically active and catalytically inactive reverse transcriptase

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

The human and African green monkey TRIM5alpha genes encode Ref1 and Lv1 retroviral restriction factor activities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Abrogation of postentry restriction of HIV-1-based lentiviral vector transduction in simian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Image reconstructions of helical assemblies of the HIV-1 CA protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Class II integrase mutants with changes in putative nuclear localization signals are primarily blocked at a postnuclear entry step of human immunodeficiency virus type 1 replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Human immunodeficiency virus type 1 Gag protein binds to cyclophilins A and B

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Pathway of vesicular stomatitis virus entry leading to infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Retroviral restriction factor TRIM5alpha is a trimer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

A dominant block to HIV-1 replication at reverse transcription in simian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

A specific region of 37 amino acid residues in the SPRY (B30.2) domain of African green monkey TRIM5alpha determines species-specific restriction of simian immunodeficiency virus SIVmac infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

A Trim5-cyclophilin A fusion protein found in owl monkey kidney cells can restrict HIV-1.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

TRIM family proteins: retroviral restriction and antiviral defence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Gene transfer vectors derived from equine infectious anemia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Human and simian immunodeficiency virus capsid proteins are major viral determinants of early, postentry replication blocks in simian cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Binding and susceptibility to postentry restriction factors in monkey cells are specified by distinct regions of the human immunodeficiency virus type 1 capsid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Restriction of human immunodeficiency virus type 1 by TRIM-CypA occurs with rapid kinetics and independently of cytoplasmic bodies, ubiquitin, and proteasome activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

TRIM5alpha mediates the postentry block to N-tropic murine leukemia viruses in human cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Evolution of cyclophilin A and TRIMCyp retrotransposition in New World primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Positive selection of primate TRIM5alpha identifies a critical species-specific retroviral restriction domain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Selection for loss of Ref1 activity in human cells releases human immunodeficiency virus type 1 from cyclophilin A dependence during infection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Cyclophilin A retrotransposition into TRIM5 explains owl monkey resistance to HIV-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

TRIM5alpha selectively binds a restriction-sensitive retroviral capsid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

59 Inhibitors of lysosomal function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Retrovirus restriction by TRIM5alpha variants from Old World and New World primates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in Old World monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Species-specific variation in the B30.2(SPRY) domain of TRIM5alpha determines the potency of human immunodeficiency virus restriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Cyclophilin A modulates the sensitivity of HIV-1 to host restriction factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Crystal structure of cyclophilin A complexed with a binding site peptide from the HIV-1 capsid protein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Kinetics of human immunodeficiency virus type 1 (HIV) DNA integration in acutely infected cells as determined using a novel assay for detection of integrated HIV DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Trim5alpha protein restricts both HIV-1 and murine leukemia virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

A single amino acid change in the SPRY domain of human Trim5alpha leads to HIV-1 restriction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Molecular recognition in the HIV-1 capsid/cyclophilin A complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

Pseudotyping human immunodeficiency virus type 1 (HIV-1) by the glycoprotein of vesicular stomatitis virus targets HIV-1 entry to an endocytic pathway and suppresses both the requirement for Nef and the sensitivity to cyclosporin A.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VIROL.2006.03.023

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VIROL.2006.03.023

1 reference

19 September 2017

1 reference